Ataraxis

Ataraxis AI is a precision-medicine company building clinical AI foundation models that make disease predictable, beginning with oncology. Founded in 2022 by Jan Witowski, MD, PhD, and Krzysztof Geras, PhD (both formerly of NYU), Ataraxis trains multi-modal AI on hundreds of millions of pathology images to assess disease aggressiveness and predict cancer recurrence, treatment response, and survival. Its first product, Ataraxis Breast, is an AI-native, clinically validated prognostic and predictive test suite for breast cancer (Recurrence Risk, Chemotherapy Benefit, and Neoadjuvant Response) delivering same-day results without exhausting physical tissue. The company is backed by Obvious Ventures, AIX Ventures, and Giant Ventures, and advised by Turing Award winner Yann LeCun. Ataraxis operates a clinician portal rather than a public developer API; this profile captures its public identity, legal, and security surface for the API Evangelist network.

Ataraxis is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Artificial Intelligence, Precision Medicine, and Oncology.

Ataraxis’ developer surface includes engineering blog, support, and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub

17.8/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareArtificial IntelligencePrecision MedicineOncologyCancer DiagnosticsMachine LearningDigital Pathology

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 17.8/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 6.8 / 20

Operational Transparency 0.7 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/ataraxis: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Get Started 1

Portal, sign-up, and the first successful call

Login

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: ataraxis
name: Ataraxis
description: Ataraxis AI is a precision-medicine company building clinical AI foundation models that make disease predictable,
  beginning with oncology. Founded in 2022 by Jan Witowski, MD, PhD, and Krzysztof Geras, PhD (both formerly of NYU), Ataraxis
  trains multi-modal AI on hundreds of millions of pathology images to assess disease aggressiveness and predict cancer recurrence,
  treatment response, and survival. Its first product, Ataraxis Breast, is an AI-native, clinically validated prognostic and
  predictive test suite for breast cancer (Recurrence Risk, Chemotherapy Benefit, and Neoadjuvant Response) delivering same-day
  results without exhausting physical tissue. The company is backed by Obvious Ventures, AIX Ventures, and Giant Ventures,
  and advised by Turing Award winner Yann LeCun. Ataraxis operates a clinician portal rather than a public developer API;
  this profile captures its public identity, legal, and security surface for the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/ataraxis/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- obvious-ventures
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/66f22558f0bee9421463707b/66f22558f0bee94214637099_ataraxis-logo-black.svg
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Healthcare
- Artificial Intelligence
- Precision Medicine
- Oncology
- Cancer Diagnostics
- Machine Learning
- Digital Pathology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/ataraxis-domain-security.yml
- type: Website
  url: https://ataraxis.ai
- type: Login
  url: https://portal.ataraxis.ai/
- type: PrivacyPolicy
  url: https://www.ataraxis.ai/privacy-policy
- type: TermsOfService
  url: https://www.ataraxis.ai/terms-conditions
- type: Blog
  url: https://www.ataraxis.ai/news-resources
- type: Support
  url: https://www.ataraxis.ai/contact-us
- type: GitHubOrganization
  url: https://github.com/ataraxis-ai
- type: LLMsTxt
  url: llms/ataraxis-llms.txt
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence